Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$777.05B | 41.7x | 95.12 | US$97.24 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.7% Upside | Upgrade to Pro+ | |
Kroger | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$45.01B | 18.3x | 0.72 | US$67.69 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.1% Upside | Upgrade to Pro+ | |
Seven i ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$38.80B | 32.5x | -1.5 | US$15.13 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seven & i Co | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$38.80B | 32.5x | -1.54 | US$15.35 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Koninklijke Ahold ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$38.48B | 19x | 9.13 | US$42.03 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.9% Downside | Upgrade to Pro+ | |
Koninklijke Ahold NV | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$38.48B | 19x | 9.28 | US$42.15 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fomento Economico Mexicano | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$36.94B | 27.4x | 0.54 | US$106.85 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6% Upside | Upgrade to Pro+ | |
Sysco | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$34.65B | 18.5x | -3.27 | US$71.51 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.7% Upside | Upgrade to Pro+ | |
Tesco PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$34.39B | 16.8x | 0.38 | US$15.89 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -15.4% Downside | Upgrade to Pro+ | |
Tesco PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$34.39B | 16.8x | 0.38 | US$5.16 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Aeon ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$25.93B | 130.2x | -3.63 | US$30.11 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coles Group | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$18.83B | 26.1x | 4.55 | US$14 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
US Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$17.90B | 34.9x | 4.38 | US$77.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7% Upside | Upgrade to Pro+ | |
Caseys | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$16.61B | 31.1x | 2.19 | US$447.51 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.9% Upside | Upgrade to Pro+ | |
Sprouts Farmers | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$16.55B | 37.9x | 0.67 | US$169.27 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.6% Upside | Upgrade to Pro+ | |
Jeronimo Martins SGPS SA ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$15.93B | 22.2x | -1.92 | US$50.65 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.8% Upside | Upgrade to Pro+ | |
Dino Polska ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$14.44B | 35.8x | 5.33 | US$73.71 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Performance Food Group Co | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$13.87B | 36.7x | -3.49 | US$88.99 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.8% Upside | Upgrade to Pro+ | |
Sendas Distribuidora | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$13.75B | 94.6x | 0.9 | US$9.94 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.1% Upside | Upgrade to Pro+ | |
CP All ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$13.24B | 17.1x | 0.57 | US$15 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Albertsons | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$12.78B | 13.4x | -0.5 | US$22.15 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.1% Upside | Upgrade to Pro+ | |
Luckin Coffee | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$10.55B | 22.1x | 0.36 | US$31.65 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24% Upside | Upgrade to Pro+ | |
Carrefour SA PK | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$10.51B | 13.4x | -0.24 | US$3.35 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.6% Downside | Upgrade to Pro+ | |
Marks and Spencer | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$10.42B | 25.5x | -0.79 | US$5.45 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marks & Spencer Group Plc | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$10.42B | 25.5x | -0.79 | US$10.48 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.7% Upside | Upgrade to Pro+ | |
Walgreens Boots | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.66B | -1.7x | -0.38 | US$11.20 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.1% Upside | Upgrade to Pro+ | |
Kesko ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.38B | 22.7x | -1 | US$12.09 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
J Sainsbury PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$8.76B | 15.8x | 0.2 | US$15.67 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -22.4% Downside | Upgrade to Pro+ | |
Shoprite ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$8.46B | 22x | 2.57 | US$15.58 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Axfood ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$6.25B | 28x | -1.96 | US$27.24 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Etablissementen Franz Colruyt ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$5.59B | 14.1x | -0.22 | US$10.11 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clicks Group | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$5.10B | 30.4x | 2.13 | US$43 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Raia Drogasil ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$4.51B | 21.1x | 1.57 | US$2.93 | 7.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DFI Retail Holdings DRC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$3.57B | -14.7x | 0.02 | US$13.46 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BBB Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$3.41B | 166.3x | US$29.60 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.5% Upside | Upgrade to Pro+ | ||
Sun Art Retail ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$2.74B | 52.1x | 0.37 | US$2.25 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
The Chefs Warehouse | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$2.60B | 38.4x | 0.6 | US$64.06 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.1% Upside | Upgrade to Pro+ | |
Weis Markets | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$2.06B | 19.2x | 3.07 | US$76.91 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hellofresh | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.93B | -10.1x | 0.03 | US$12.16 | -5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
United Natural Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.85B | -22.3x | -0.73 | US$30.43 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.5% Downside | Upgrade to Pro+ | |
Guardian Pharmacy Services | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.43B | -15.7x | US$21.45 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.5% Upside | Upgrade to Pro+ | ||
Vital Farms | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.42B | 26.9x | 0.95 | US$31.78 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.8% Upside | Upgrade to Pro+ | |
Grocery Outlet | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.35B | 81.3x | -1.04 | US$13.75 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.2% Upside | Upgrade to Pro+ | |
SPAR ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.25B | 13.6x | -1.13 | US$6.85 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Green Thumb Industries | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.25B | 26.8x | -2.09 | US$5.25 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ingles | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.19B | 19.2x | -0.28 | US$62.53 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pick N Pay ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.17B | -4.9x | 0 | US$6.84 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Robinsons Retail Holdings Inc | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$950.84M | 9.4x | -0.31 | US$6.59 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SpartanNash Co | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$658.80M | 1,950x | -21.42 | US$19.48 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.9% Upside | Upgrade to Pro+ | |
Village Super Market | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$559.05M | 10.4x | 2.8 | US$37.99 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |